Chidozie Ugwumba
Director/Board Member at CTx Operations, Inc.
Net worth: 9 M $ as of 29/04/2024
Chidozie Ugwumba active positions
| Companies | Position | Start | End |
|---|---|---|---|
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Director/Board Member | 30/11/2020 | - |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Director/Board Member | - | - |
Symbiosis Capital Management LLC
 Symbiosis Capital Management LLC Investment ManagersFinance Symbiosis Capital Management LLC (SymBiosis) is a venture capital firm founded in 2019. The firm is headquartered in Bentonville, Arkansas. | Private Equity Investor | 31/12/2020 | - |
Micronoma, Inc.
 Micronoma, Inc. Medical/Nursing ServicesHealth Services Micronoma, Inc. is a cancer-detection company that uses signals from circulating microbial nucleic acids in blood to diagnose cancer at an early stage with microbiome-driven liquid biopsy technology. Micronoma is headquartered in San Diego, CA. The company aims to revolutionize and advance the practice of early cancer diagnostics and personalized treatment through sensitive microbiome techniques, ensuring that patients' needs are identified and addressed by their clinicians at the earliest stage for a better chance to live longer, healthier lives. The company was founded in 2019 by Sandrine Miller-Montgomery, Greg Poore, Rob Knight, and Magda Marquet. Sandrine Miller-Montgomery has been the CEO since 2019. | Director/Board Member | - | - |
Career history of Chidozie Ugwumba
Former positions of Chidozie Ugwumba
| Companies | Position | Start | End |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director/Board Member | 30/11/2020 | 31/03/2024 |
| Independent Dir/Board Member | 30/11/2020 | 31/03/2024 | |
| CLENE INC. | Director/Board Member | 31/12/2019 | 14/02/2023 |
| Independent Dir/Board Member | 31/12/2019 | 14/02/2023 | |
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Director/Board Member | 31/12/2020 | 30/12/2022 |
WIT LLC
 WIT LLC Investment ManagersFinance WIT LLC is a family offices headquartered in Washington, DC. The firm is owned by Walton Enterprises LLC and they manage the assets of the Walton family and their related entities. | Director of Investments | 31/12/2017 | 31/12/2020 |
| MAAT PHARMA | Director/Board Member | 31/12/2019 | 31/12/2020 |
| ░░░░░░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░ ░░ ░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░ | - | - |
Training of Chidozie Ugwumba
| Johnson Graduate School of Management | Masters Business Admin |
| Amherst College | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Statistics
International
| United States | 15 |
| France | 2 |
Operational
| Director/Board Member | 7 |
| Independent Dir/Board Member | 2 |
| Masters Business Admin | 2 |
Sectoral
| Finance | 6 |
| Health Technology | 6 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CLENE INC. | Health Technology |
| MAAT PHARMA | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Neuberger Berman BD LLC
 Neuberger Berman BD LLC Investment ManagersFinance Neuberger Berman BD LLC is a SEC-registered investment advisor and mutual fund manager headquartered in New York City. It is directly owned by Neuberger Berman Investment Advisers LLC, which is an indirect, wholly-owned subsidiary of Neuberger Berman Group LLC, which is owned by NBSH Acquisition LLC. The firm traces their origin back to the 1939 founding of Neuberger & Berman, its predecessor firm. In 1950, Neuberger Berman became one of the first firms to offer a no-load mutual fund to individual investors. Neuberger Berman BD manages a range of equity, fixed income, private equity and hedge fund strategies on behalf of institutions, advisors and individual investors worldwide. | Finance |
WIT LLC
WIT LLC Investment ManagersFinance WIT LLC is a family offices headquartered in Washington, DC. The firm is owned by Walton Enterprises LLC and they manage the assets of the Walton family and their related entities. | Finance |
Hunting Hill Global Capital LLC
 Hunting Hill Global Capital LLC Investment ManagersFinance Hunting Hill Global Capital LLC (Hunting Hill) is an independent hedge fund management firm headquartered in New York City. The firm was founded by Adam Guren and Chidozie Ugwumba in 2010. Hunting Hill serves as investment manager to pooled investment vehicles and separately managed accounts. Investors in the Hunting Hill Funds are financially sophisticated individuals and institutional investors. | Finance |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
Symbiosis Capital Management LLC
Symbiosis Capital Management LLC Investment ManagersFinance Symbiosis Capital Management LLC (SymBiosis) is a venture capital firm founded in 2019. The firm is headquartered in Bentonville, Arkansas. | Finance |
Micronoma, Inc.
Micronoma, Inc. Medical/Nursing ServicesHealth Services Micronoma, Inc. is a cancer-detection company that uses signals from circulating microbial nucleic acids in blood to diagnose cancer at an early stage with microbiome-driven liquid biopsy technology. Micronoma is headquartered in San Diego, CA. The company aims to revolutionize and advance the practice of early cancer diagnostics and personalized treatment through sensitive microbiome techniques, ensuring that patients' needs are identified and addressed by their clinicians at the earliest stage for a better chance to live longer, healthier lives. The company was founded in 2019 by Sandrine Miller-Montgomery, Greg Poore, Rob Knight, and Magda Marquet. Sandrine Miller-Montgomery has been the CEO since 2019. | Health Services |
Partners Group Inc (United States)
 Partners Group Inc (United States) Investment ManagersFinance Partners Group Inc. (United States) is a Private Equity/Venture Capital firm, a subsidiary of Partners Group (Private Equity) founded in 2000. The firm is headquartered in Houston. | Finance |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
- Stock Market
- Insiders
- Chidozie Ugwumba
- Experience